Recent Company News

• 02:30 PM ET Feb 11, 2026
  

  StreetAccount Event preview: AAP v RFK Jr PI hearing on Friday the 13th

• 12:57 PM ET Feb 11, 2026
  

  No association between mRNA COVID-19 vaccination during pregnancy and autism in children, new research shows

• 02:56 PM ET Feb 06, 2026
  

  StreetAccount Sector Summary: Healthcare Monthly Recap - January 2026

• 04:30 PM ET Feb 02, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:47 AM ET Feb 02, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 08:29 AM ET Feb 02, 2026
  

  StreetAccount Summary - US Pre-market trading

• 06:20 AM ET Feb 02, 2026
  

  BioNTech downgraded to market perform from outperform at Leerink Partners ($113.75, 0.00)

• 09:15 AM ET Jan 28, 2026
  

  Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment

• 07:08 AM ET Jan 21, 2026
  

  BioNTech receives FDA Fast Track Designation for BNT113 in HPV16+ head and neck cancer ($105.56, 0.00)

• 12:38 AM ET Jan 17, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap